Amanote Research
Register
Sign In
102. AAV8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial Hypercholesterolemia
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36674-6
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2011
Authors
Unknown
Publisher
Elsevier BV
Related search
Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia
Current Atherosclerosis Reports
Cardiovascular Medicine
Cardiology
Genetic Determinants of Plasma HDL-cholesterol Levels in Familial Hypercholesterolemia
European Journal of Human Genetics
Genetics
Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High-Dose Statin Therapy
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Homozygous Familial Hypercholesterolemia “Rare Disease”
Journal of Glycomics & Lipidomics
Elevated Cholesterol and Bile Acid Synthesis in a Young Patient With Homozygous Familial Hypercholesterolemia
Journal of Clinical Investigation
Medicine
Treatment of Homozygous Familial Hypercholesterolemia: Challenges and Latest Development
Cardio-Ankle Vascular Index in Heterozygous Familial Hypercholesterolemia
Journal of Atherosclerosis and Thrombosis
Biochemistry
Internal Medicine
Cardiovascular Medicine
Cardiology
Carotid and Aortic Stiffness in Patients With Heterozygous Familial Hypercholesterolemia
Artery Research
Epipolymorphisms Within Lipoprotein Genes Contribute Independently to Plasma Lipid Levels in Familial Hypercholesterolemia
Epigenetics
Cancer Research
Medicine
Molecular Biology